glp-1 companies Insurance scrambling to support need for drugs - Insurance News As GLP-1 drugs boom, other

A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007

Patellar Tendinopathy (Jumper's Knee) The patellar tendon connects the bottom of the kneecap to the tibial tuberosity (the bump below your knee)

Aug 2019;35(8):695-700

Those studies support the broader repair mechanism

Nasal saline sprays Helps with nose dryness and nosebleeds